DOSING REGIMENS FOR TREATMENT OF CEA-EXPRESSING CANCERS

The present disclosure provides compositions and methods for treating CEA-expressing cancers. Methods for dosing a patient with an antibody that binds to CEA and human CD3 are also provided. La présente invention concerne des compositions et des procédés pour traiter des cancers exprimant CEA. La pr...

Full description

Saved in:
Bibliographic Details
Main Authors LUTTERBUESE, PETRA, HAMMOND, SCOTT, RYAN, PATRICIA, REN, SONG, AMANN, MARIA
Format Patent
LanguageEnglish
French
Published 24.01.2013
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides compositions and methods for treating CEA-expressing cancers. Methods for dosing a patient with an antibody that binds to CEA and human CD3 are also provided. La présente invention concerne des compositions et des procédés pour traiter des cancers exprimant CEA. La présente invention concerne en outre des procédés pour administrer à un patient un anticorps qui se lie à CEA et CD3 humain.
Bibliography:Application Number: WO2011US44339